Evidence-based strategies for managing gastrointestinal symptoms during GLP-1 therapy should be the first-line approach before considering supplemental interventions
On average participants had 3 band adjustments during the trial, this number did not significantly differ between groups (L:3.0, P:3.0, p = 0.39)
This product is intended solely for in-vitro research
Your Next Step: Prioritise Your Hormone Health Today If you are on Mounjaro , Wegovy , or any GLP-1 agonist and youre also using HRT, dont leave things to chance
That means dosing is adjusted thoughtfully, side effects are monitored, and follow-up matters
The trials reported that patients treated with the drug "used significantly less systemic corticosteroids" and reported "fewer episodes of PLE" compared to those treated with a placebo